Welcome to LookChem.com Sign In|Join Free
  • or
Pheophorbide A is a chlorophyll-related compound that has garnered significant attention for its potential anti-tumor and anti-cancer properties. It is derived from the natural breakdown of chlorophyll, which is the primary pigment in plants responsible for photosynthesis. Pheophorbide A exhibits unique characteristics that make it a promising candidate for various therapeutic applications, particularly in the field of oncology.

15664-29-6

Post Buying Request

15664-29-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15664-29-6 Usage

Uses

Used in Anticancer Applications:
Pheophorbide A is used as an anti-cancer agent for its potential to combat tumor growth and cancer cell proliferation. It has been studied for its effects on inducing oxidative stress and cell death in various cancer cell lines, including L. amazonensis and HeLa cells. The compound's ability to generate reactive oxygen species (ROS) upon light activation makes it a viable option for targeting and destroying cancerous cells.
Used in Photodynamic Therapy (PDT):
Pheophorbide A is used as a photosensitizer in the treatment of oral cancer cell lines. In this application, the compound is administered to patients, and when exposed to a specific wavelength of light, it becomes activated and generates ROS. These reactive molecules can cause significant damage to the cancer cells, leading to their destruction. Pheophorbide A's role as a photosensitizer in PDT offers a targeted and minimally invasive approach to cancer treatment, with the potential for reduced side effects compared to traditional chemotherapy and radiation therapies.

Biochem/physiol Actions

Pheophorbide-a, due to its photosensitizing effect, may serve as a promising bioactive compound to treat leishmaniasis. It is a metabolite of chlorophyll and possesses immunostimulation functionality. Pheophorbide-a is a photosensitizer for the photodynamic therapy. It is an ATP Binding Cassette Subfamily G Member 2 (ABCG2) transporter specific substrate. Overexpression of ATP-binding cassette (ABC) transporters in cancer cells is associated with the multidrug resistance phenotype.

Enzyme inhibitor

This chlorophyll a degradation intermediate (MW = 579.68 g/mol; CAS 15664-29-6), which is identical to chlorophyll a, except for the absence of the latter’s magnesium ion and ester at the 17-position, is obtained by acid hydrolysis of chlorophyll a. Pheophorbide a inhibits acyl-CoA:cholesterol acyltransferase and magnesium protoporphyrin IX methyltransferase, acts as an endothelin receptor antagonist, and also induces apoptosis. Pheophorbide a is also as an anti-tumor promoter.

Check Digit Verification of cas no

The CAS Registry Mumber 15664-29-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,6,6 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 15664-29:
(7*1)+(6*5)+(5*6)+(4*6)+(3*4)+(2*2)+(1*9)=116
116 % 10 = 6
So 15664-29-6 is a valid CAS Registry Number.

15664-29-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (SML1218)  Pheophorbide-a  ≥90% (HPLC)

  • 15664-29-6

  • SML1218-10MG

  • 609.57CNY

  • Detail
  • Sigma

  • (SML1218)  Pheophorbide-a  ≥90% (HPLC)

  • 15664-29-6

  • SML1218-50MG

  • 2,476.89CNY

  • Detail

15664-29-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name pheophorbide a

1.2 Other means of identification

Product number -
Other names Pheophorbide a

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15664-29-6 SDS

15664-29-6Synthetic route

pheophytin a
603-17-8

pheophytin a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
In water; trifluoroacetic acid at 0℃; for 0.916667h;92%
pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride In acetone at 20 - 25℃; for 22h;80%
With hydrogenchloride; water In acetone at 20℃; for 24h;70%
Acidic aq. solution;
pheophytin a
603-17-8

pheophytin a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With trifluoroacetic acid In water at 0℃; for 1h; Inert atmosphere; Darkness;58%
With hydrogenchloride
With enzyme-substance from heracleum spondylium
chlorophyll-a
53321-11-2, 479-61-8

chlorophyll-a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride; water In diethyl ether at 0℃; for 0.5h;
pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride In diethyl ether
methylchlorophyllide-a

methylchlorophyllide-a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride
Conditions
ConditionsYield
With trifluoroacetic acid In water at 0℃; for 1h; Inert atmosphere; Darkness;1.3 g
chlorophyllide α

chlorophyllide α

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride In water; acetone at 25℃; Kinetics; pH-value;
With sulfuric acid In acetone at 20℃; Darkness;
With sulfuric acid
pheophytin a

pheophytin a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride; water In diethyl ether for 2h;Ca. 20 g
α-chlorophyll

α-chlorophyll

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
Stage #1: chlorophyll α With sulfuric acid In dichloromethane; water Darkness;
Stage #2: With sulfuric acid In methanol
With hydrogenchloride In diethyl ether; water at 0 - 5℃; for 0.5h;
chlorophyll a

chlorophyll a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride In diethyl ether Inert atmosphere;
pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
In methanol; diethyl ether at 0℃; for 0.25h;95%
methanol
67-56-1

methanol

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With pyridine; chloroformic acid ethyl ester In tetrahydrofuran for 0.166667h;88%
With hydrogenchloride
With chlorophyllase-substance
With sulfuric acid
pheophorbide-a
15664-29-6

pheophorbide-a

pyropheophorbide a
24533-72-0

pyropheophorbide a

Conditions
ConditionsYield
In 2,4,6-trimethyl-pyridine for 0.666667h; Reflux;85%
With pyridine for 5h; Heating;78%
With biphenyl
methanol
67-56-1

methanol

N-ε-tert-butoxycarbonyl-L-lysine methyl ester hydrochloride
2389-48-2

N-ε-tert-butoxycarbonyl-L-lysine methyl ester hydrochloride

pheophorbide-a
15664-29-6

pheophorbide-a

C48H62N6O9

C48H62N6O9

Conditions
ConditionsYield
Stage #1: pheophorbide-a With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 0.5h;
Stage #2: N-ε-tert-butoxycarbonyl-L-lysine methyl ester hydrochloride In N,N-dimethyl-formamide for 1h;
Stage #3: methanol With sodium methylate for 8h;
85%
pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide a hydrazide

pheophorbide a hydrazide

Conditions
ConditionsYield
Stage #1: pheophorbide-a With 1-hydroxy-pyrrolidine-2,5-dione; 1,2-dichloro-ethane In dichloromethane at 20℃; for 0.5h;
Stage #2: With hydrazine In dichloromethane at 20℃; for 4h;
83%
ethylene glycol
107-21-1

ethylene glycol

pheophorbide-a
15664-29-6

pheophorbide-a

phoephorbide a ethylene glycol monoester
61774-49-0

phoephorbide a ethylene glycol monoester

Conditions
ConditionsYield
With pyridine; isobutyl chloroformate In tetrahydrofuran for 0.25h;72%
3-[(4Z,10Z,15Z,19Z)-(2S,3S)-18-(3-Amino-propylcarbamoyl)-13-ethyl-20-methoxycarbonylmethyl-3,7,12,17-tetramethyl-8-vinyl-2,3,22,24-tetrahydro-porphin-2-yl]-propionic acid methyl ester

3-[(4Z,10Z,15Z,19Z)-(2S,3S)-18-(3-Amino-propylcarbamoyl)-13-ethyl-20-methoxycarbonylmethyl-3,7,12,17-tetramethyl-8-vinyl-2,3,22,24-tetrahydro-porphin-2-yl]-propionic acid methyl ester

pheophorbide-a
15664-29-6

pheophorbide-a

C74H82N10O9
137445-88-6

C74H82N10O9

Conditions
ConditionsYield
With N-(3-dimethylaminopropyl)-N-ethylcarbodiimide67%
ethylenediamine
107-15-3

ethylenediamine

pheophorbide-a
15664-29-6

pheophorbide-a

C72H76N10O8

C72H76N10O8

Conditions
ConditionsYield
Stage #1: pheophorbide-a With pyridine; dichloromethane; di-tert-butyl dicarbonate at 0℃; for 0.5h;
Stage #2: ethylenediamine In dichloromethane at 20℃; for 2h;
67%
pheophorbide-a
15664-29-6

pheophorbide-a

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose
4064-06-6

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose

C47H54N4O10

C47H54N4O10

Conditions
ConditionsYield
With dmap; 2-chloro-1-methyl-pyridinium iodide In dichloromethane for 3h; Reflux;60%
pheophorbide-a
15664-29-6

pheophorbide-a

20-chloropheophorbide a

20-chloropheophorbide a

Conditions
ConditionsYield
With N-chloro-succinimide In dichloromethane Inert atmosphere;57%
pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide-α-paclitaxel

pheophorbide-α-paclitaxel

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 4h;54%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 4h;54%
doxorubicin hydrochloride
25316-40-9

doxorubicin hydrochloride

pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide-α-doxorubicin

pheophorbide-α-doxorubicin

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 4h;53%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 4h;53%
phoephorbide a ethylene glycol monoester
61774-49-0

phoephorbide a ethylene glycol monoester

pheophorbide-a
15664-29-6

pheophorbide-a

bis(pheophorbide a)ethylene glycol diester
73197-83-8

bis(pheophorbide a)ethylene glycol diester

Conditions
ConditionsYield
With dmap; 1-methanesulfonyloxy-1,2,3-benzotriazole In dichloromethane for 2.16667h;47%
2-(hydroxymethyl)-6-exo-(1,7,7-trimethylbicyclo[2.2.1]-hept-2-yl)phenol

2-(hydroxymethyl)-6-exo-(1,7,7-trimethylbicyclo[2.2.1]-hept-2-yl)phenol

pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide a 17-(2-hydroxy-3-(exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)benzyl)-benzyl ester

pheophorbide a 17-(2-hydroxy-3-(exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)benzyl)-benzyl ester

Conditions
ConditionsYield
Stage #1: pheophorbide-a With thionyl chloride
Stage #2: 2-(hydroxymethyl)-6-exo-(1,7,7-trimethylbicyclo[2.2.1]-hept-2-yl)phenol With triethylamine In dichloromethane at 25℃; for 8h;
46%
chlorin e6 13-N-(2-aminoethyl)amide-15,17-dimethyl ester

chlorin e6 13-N-(2-aminoethyl)amide-15,17-dimethyl ester

pheophorbide-a
15664-29-6

pheophorbide-a

15,17-dimethyl ester of e6-chlorinyl-13-N-[2-(N-17(3)-pheophorbidyl)aminoethyl]amide

15,17-dimethyl ester of e6-chlorinyl-13-N-[2-(N-17(3)-pheophorbidyl)aminoethyl]amide

Conditions
ConditionsYield
Stage #1: pheophorbide-a With pyridine; di-tert-butyl dicarbonate In dichloromethane at 0℃; for 0.25h;
Stage #2: chlorin e6 13-N-(2-aminoethyl)amide-15,17-dimethyl ester With pyridine In dichloromethane at 20℃; for 1h;
44%
pheophorbide-a
15664-29-6

pheophorbide-a

A

132-(methoxycarbonyl)phytoporphyrin
34705-25-4

132-(methoxycarbonyl)phytoporphyrin

B

132-(methoxycarbonyl)-31-oxophytoporphyrin
127594-32-5

132-(methoxycarbonyl)-31-oxophytoporphyrin

Conditions
ConditionsYield
With air; hydrogen iodide In acetic acid for 5h; Ambient temperature;A n/a
B 40%
4-aminobenzenemethanol
623-04-1

4-aminobenzenemethanol

pheophorbide-a
15664-29-6

pheophorbide-a

C42H43N5O5

C42H43N5O5

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 4h;38%
4-aminobenzenemethanol
623-04-1

4-aminobenzenemethanol

pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide-α-4-aminobenzyl alcohol

pheophorbide-α-4-aminobenzyl alcohol

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 4h;38%
pheophorbide-a
15664-29-6

pheophorbide-a

purpurin 18
25465-77-4

purpurin 18

Conditions
ConditionsYield
With oxygen; potassium hydroxide In diethyl ether; isopropyl alcohol for 12h;34.4%
With 1,4-dioxane; propan-1-ol; potassium hydroxide weiteres Reagens: Aether; weitere Angaben: Erwaermen des Reaktionsprodukts in Dioxan;
With potassium hydroxide; oxygen In methanol
pheophorbide-a
15664-29-6

pheophorbide-a

sphingosine-1-phosphocholine

sphingosine-1-phosphocholine

C58H83N6O9P

C58H83N6O9P

Conditions
ConditionsYield
Stage #1: pheophorbide-a With HATU In N,N-dimethyl-formamide at 20℃; for 1h; Darkness; Inert atmosphere;
Stage #2: sphingosine-1-phosphocholine With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 24h; Darkness; Inert atmosphere;
30%
2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-β-D-glucopyranosylamine
59044-96-1, 93079-64-2, 120575-75-9, 30854-63-8

2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-β-D-glucopyranosylamine

pheophorbide-a
15664-29-6

pheophorbide-a

C61H71N5O21

C61H71N5O21

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane at 20℃; for 4h;30%
pheophorbide-a
15664-29-6

pheophorbide-a

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose
4064-06-6

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose

C58H70N4O15

C58H70N4O15

Conditions
ConditionsYield
With dmap; 2-chloro-1-methyl-pyridinium iodide In toluene for 3h; Reflux;30%
pheophorbide-a
15664-29-6

pheophorbide-a

(17S,18R)-174,18-lactonopheophorbide a

(17S,18R)-174,18-lactonopheophorbide a

Conditions
ConditionsYield
With 2,3-dicyano-5,6-dichloro-p-benzoquinone In chloroform at 20℃; for 0.5h;28.3%
pheophorbide-a
15664-29-6

pheophorbide-a

C49H55N5O13

C49H55N5O13

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane at 20℃; for 4h;28%
C36H35NO13

C36H35NO13

pheophorbide-a
15664-29-6

pheophorbide-a

C71H69N5O17

C71H69N5O17

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 20℃;24%
C36H35NO13
1338699-28-7

C36H35NO13

pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide-α-2-hydroxycinnamic acid-doxorubicin

pheophorbide-α-2-hydroxycinnamic acid-doxorubicin

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 20℃;24%
pheophorbide-a
15664-29-6

pheophorbide-a

20-bromopheophorbide a

20-bromopheophorbide a

Conditions
ConditionsYield
With N-Bromosuccinimide In dichloromethane Inert atmosphere;10%

15664-29-6Related news

Original researchInvolvement of a Putative Bipartite Transit Peptide in Targeting Rice Pheophorbide A (cas 15664-29-6) Oxygenase into Chloroplasts for Chlorophyll Degradation during Leaf Senescence09/08/2019

Leaf senescence is one of the major factors contributing to the productivity and the grain quality in crops. The regulatory mechanism of leaf senescence remains largely unknown. Here, we report the identification and characterization of a rice early senescence 1 (eas1) mutant, which displayed an...detailed

Folate-modified PLGA nanoparticles for tumor-targeted delivery of Pheophorbide A (cas 15664-29-6) in vivo09/05/2019

Targeted drug delivery has been an important issue for tumor therapy including photodynamic therapy (PDT). The purpose of our study is to increase the targeting efficiency of photosensitizer (PS) using folate-modified nanoparticles (NPs) to tumor site in vivo. Folate receptor is over-expressed o...detailed

The photodynamic action of Pheophorbide A (cas 15664-29-6) induces cell death through oxidative stress in Leishmania amazonensis09/03/2019

Leishmaniasis is a disease caused by hemoflagellate protozoa, affecting millions of people worldwide. The difficulties of treating patients with this parasitosis include the limited efficacy and many side effects of the currently available drugs. Therefore, the search for new compounds with leis...detailed

Sodium Pheophorbide A (cas 15664-29-6) has photoactivated fungicidal activity against Pestalotiopsis neglecta09/01/2019

Sodium pheophorbide a (SPA) is a natural photosensitizer. To explore its antifungal activity and mechanism, we studied its inhibitory effects on spore germination and mycelial growth of Pestalotiopsis neglecta. We used sorbitol, 2-thiobarbituric acid (TBA) and electron microscopy to determine it...detailed

15664-29-6Relevant academic research and scientific papers

ELECTROPHILIC SUBSTITUTION AT THE δ-METHINE BRIDGE OF PHEOPHORBIDE a AND a'

Hynninen, Paavo H.,Loetjoenen, Simo

, p. 1845 - 1846 (1981)

A chloro-substituted derivative was prepared from chlorophyll a'.The derivative was shown to be δ-chloro-methyl pheophorbide a by UV/VIS, MS and 1H NMR.

Anti-tumor evaluation of a novel methoxyphenyl substituted chlorin photosensitizer for photodynamic therapy

Cao, Lei,Dong, Yi,Li, Guangzhe,Li, Yueqing,Wang, Liu,Zhao, Weijie

, (2020)

Photodynamic therapy (PDT) is a non-invasive and innovative therapeutic approach which has been increasingly applied in clinical cancer therapy. As the central element of PDT, the development of novel photosensitizers (PSs) with longer absorption wavelength, proper lipophilic/hydrophilic profiles, target tissue selectivity, and higher photo?/lowest dark-cytotoxicity is a challenging task. Previously, we designed and synthesized a series of novel long-wavelength chlorin e6 (Ce6)-based PSs via introducing aromatic groups to the vinyl of Ce6 skeleton. The new formed compounds with π-extension system exhibited improved photodynamic effects and spectral characteristics. Among these π-conjugated chlorin PSs, (E)-32-(4-methoxyphenyl)-chlorin e6, named A15, was expected to be a potent antitumor candidate as a PDT agent due to its good photobiological properties. Herein, in this work, we evaluated the effectiveness of A15 in cancer PDT. In vitro, a novel rare earth probe, ATTA-Eu3+ was applied to detect the singlet oxygen (1O2) production of A15 in solution and human hepatoma HepG2 cells, respectively. Moreover, A15 exhibited strong phototoxicity and weak dark cytotoxity to HepG2 cells. In H22 tumor bearing mice, A15 showed excellent tumor accumulation ability via i.v. administration and induced tumor regression, followed by laser treatment. These results indicated that A15 is a potential novel π–extension chlorin-type PS for PDT applications.

Effect of dietary chlorophyll derivatives on mutagenesis and tumor cell growth

Chernomorsky, Simon,Segelman, Alvin,Poretz, Ronald D.

, p. 313 - 322 (1999)

Much attention in recent years has been given to the antigenotoxicity of chlorophyll. Chlorophyll, however, is known to be converted into pheophytin, pyropheophytin, and pheophorbide in processed vegetable food and following ingestion by humans. Studies were conducted on the antimutagenic and tumoricidal potencies of these compounds. All the chlorophyll derivatives tested exhibit identical antimutagenic effect towards 3-methylcholanthrene (3-MC), suggesting that the porphyrin nucleus may complex directly with the mutagen. It does not exclude, however, another mechanism of activity involving inactivation the enzymatic transformation of 3-MC. In contrast, the action of N'-nitro-N'-nitrosoguanidine (MNNG) depends upon structural differences between the chlorophyll derivatives. It is significantly lower when the phytol-containing pheophytin and pyropheophytin are tested as to that of the phytol-lacking pheophorbide. The higher concentrations of the chlorophyll derivatives were required to reduce the mutagenicity of MNNG than needed for 3-MC. The cytotoxicity of chlorophyll derivatives against tumor cells also was evaluated. The cellular uptake and inhibition of myeloma cell multiplicity were found to be greater for pheophorbide than for pheophytin. Calculated on the amount of cell associated chlorophyll derivative, however, pheophytin was more cytostatic/cytotoxic than pheophorbide. The results presented in this report indicate that food sources that yield chlorophyll derivatives may play a significant role in cancer prevention.

Synthesis of potential antitumor agents, dimeric and trimeric chlorins, from methylpheophorbide a

Belykh,Mal'Shakova,Yudina,Zavadskaya,Khudyaev,Kuchin

, p. 719 - 728 (2011)

A series of dimeric and trimeric chlorins were synthesized from methylpheophorbide a. They are potential photosensitizers for photodynamic therapy in oncology. The macrocycles were conjugated due to the formation of ester and amide bonds. The carboxy groups were activated and catalytic transesterification was carried out to form the ester bond. The amide bond was formed using carboxy group activation; in several cases, amidation of the ester group in position 13(2) of the exocycle of methylpheophorbide α was carried out, which does not require activation.

Design, synthesis and biological evaluation of novel 31-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives as potent photosensitizers for photodynamic therapy

Zhang, Xing-Jie,Han, Gui-Yan,Guo, Chang-Yong,Ma, Zhi-Qiang,Lin, Mei-Yu,Wang, Yuan,Miao, Zhen-Yuan,Zhang, Wan-Nian,Sheng, Chun-Quan,Yao, Jian-Zhong

, (2020)

This study aimed to improve the biological effectiveness and pharmacokinetic properties of chlorin e6, a second-generation photosensitizer (PS), for tumor photodynamic therapy (PDT). Herein, the novel 31-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives 3a, 3b, 3c and 8 were synthesized and their photophysical properties and in vitro bioactivities such as phototoxicity against A549, HeLa and melanoma B16–F10 cells, reactive oxygen species (ROS) production and subcellular localization were evaluated. In addition, preferred target compounds were also investigated for their in vivo pharmacokinetic in SD rats and in vivo antitumor efficacies in C57BL/6 mice bearing melanoma B16–F10 cells. Apparently, simultaneous introduction of amino acid residue and n-hexyloxy chain in chlorin e6 made a significant improvement in photophysical properties, ROS production, in vitro and in vivo PDT efficacy. Encouragingly, all target compounds showed higher in vitro phototoxicity than Talaporfin, and that 3c (152-Lys) exhibited strongest phototoxicity and highest dark toxicity/phototoxicity ratio, followed by 8 (131-Asp), 3a (152-Asp) and 3b (152-Glu). Moreover, in vivo PDT antitumor efficacy of 3a, 3c and 8 was all better than that of Talaporfin, and that both 3c and 8 had stronger PDT antitumor efficiency than 3a. The overall results suggested that these novel 31-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives, especially 3c and 8, might be potential antitumor candidate drugs for clinical treatment of melanoma by PDT.

Synthesis and biological evaluation of new water-soluble photoactive chlorin conjugate for targeted delivery

Otvagin, Vasilii F.,Nyuchev, Alexander V.,Kuzmina, Natalia S.,Grishin, Ivan D.,Gavryushin, Andrei E.,Romanenko, Yuliya V.,Koifman, Oscar I.,Belykh, Dmitrii V.,Peskova, Nina N.,Shilyagina, Natalia Yu,Balalaeva, Irina V.,Fedorov, Alexey Yu.

, p. 740 - 750 (2018)

A new water-soluble conjugate, consisting of a chlorin-based photosensitizing part, and a 4-arylaminoquinazoline moiety with high potential affinity to an epidermal growth factor receptors (EGFR) and vascular endothelial growth factor receptors (VEGFR), suitable for photodynamic therapy (PDT), was synthesized starting from methylpheophorbide-a in seven steps. An increased accumulation of this compound in A431 cells with high level of EGFR expression, in comparison with CHO and HeLa cells with low EGFR expression was observed. The prepared conjugate exhibits dark and photoinduced cytotoxicity at micromolar concentrations with IC50dark/IC50light ratio of 11–18. In tumor-bearing mice, the conjugate preferentially accumulates in the tumor tissue.

Synthesis of chlorins with a distal vinyl group

Mal'Shakova,Belykh,Kuchin

, p. 197 - 200 (2007)

A series of chlorins containing a vinyl group on the periphery of the chlorin ring that was attached by linkers of various length, potential monomers for synthesis of polymers containing chlorin via copolymerization, was synthesized from methylpheophorbide a.

Synthesis of pheophorbide-a conjugates with anticancer drugs as potential cancer diagnostic and therapeutic agents

You, Hyun,Yoon, Hyo-Eun,Yoon, Jung-Hoon,Ko, Hyojin,Kim, Yong-Chul

, p. 5383 - 5391 (2011)

Pheophorbide-a, a chlorine based photosensitizer known to be selectively accumulated in cancer cells, was conjugated with anticancer drugs, doxorubicin and paclitaxel in the purpose of selective cancer diagnosis and therapy. Pheophorbide-a was conjugated with anticancer drugs via directly and by the use of selective cleavage linkers in cancer cell. The fluorescence of pheophorbide-a and doxorubicin conjugate by excitation at 420 or 440 nm was greatly diminished possibly by the energy transfer mechanism between two fluorescent groups. However, upon treatment in cancer cells, the conjugate showed to be cleaved to restore each fluorescence of pheophorbide-a and doxorubicin after 48 h of incubation. Also, pheophorbide-a conjugates either with doxorubicin and paclitaxel inhibited the growth of various cancer cells more potently than pheophorbide-a, which displayed very weak inhibitory activity. The results indicated that the pheophorbide-a conjugates with anticancer drugs could be utilized for selective cancer therapy as well as for the fluorescence detection of cancer.

Distribution of chlorophyll- and bacteriochlorophyll-derived photosensitizers in human blood plasma

Dandler, Joerg,Wilhelm, Brigitte,Scheer, Hugo

, p. 182 - 193 (2010)

Chlorophylla and, in particular, bacteriochlorophyll a derivatives are promising candidates for photosensitizers in photodynamic therapy. The distribution of 21 (bacterio)chlorophyll derivatives among human blood plasma fractions was studied by iodixanol gradient ultracentrifugation and in situ absorption spectroscopy. Modifications of the natural pigments involved the central metal (Mg2+, Zn2+, Pd2+, none), the isocyclic ring (closed, open and taurinated), substituents at C-3 (vinyl, acetyl, 1-hydroxyethyl) and C-173 (phytyl ester, free acid). Cellular blood components bound only a small fraction of the pigments. Distribution among low-density lipoproteins (LDL), high-density lipoproteins (HDL) and high-density proteins (HDP) of the plasma was influenced as follows: (1) application in Cremophor EL slightly altered pigment distribution by lipoprotein modification, (2) only very polar pigments with multiple hydrophilic substituents showed substantial HDP binding, (3) the presence of the esterifying alcohol at C-173 caused enrichment in LDL, this was more pronounced with bacteriochlorophylls than with chlorophylls, (4) substituents at C-3 had only little influence on the distribution, (5) Zn2+-complexes were enriched in HDL compared to Mg2+ and Pd2+ complexes, indicating specific binding of the former. Equilibration of pigments among the different fractions was largely complete within 3 h.

Synthesis of Covalently Linked dimeric Derivatives of Chlorophyll a, Pyrochlorophyll a, Chlorophyll b, and Bacteriochlorophyll a

Wasielewski, Michael R.,Svec, Walter A.

, p. 1969 - 1974 (1980)

Bis(chlorophyllide) ethylene glycol diesters were prepared for each of the title compounds.Pheophytins a and b isolated from alfalfa and bacteriochlorophyll a isolated from R.sphaeroides were treated with 80percent aqueous trifluoroacetic acid to yield the corresponding pheorbides.Pyropheophorbide was prepared by a literature procedure.Carbonic anhydride and benzotriazole-1-methanesulfonate activation methods were used in the esterification of the pheophorbides with ethylene glycol at ambient temperature.Each method yielded 75percent+ of the pheophorbide ethylene glycol monoester.These monoesters were treated with equimolar amounts of the corresponding pheophorbide by using benzotriazole-1-methanesulfonate/4-(dimethylamino)pyridine in CH2Cl2 or dicyclohexylcarbodiimide/4-(dimethylamino)pyridine in CH2Cl2 at ambient temperature.Yields of bis-(pheophorbide) ethylene glycol diesters averaged about 50percent for the former method and 70percent for the latter method.Insertion of the magnesium atoms into the a series macrocycles was accomplished with iodomagnesium 2,6-di-tert-butyl-4-methylphenolate, IMgBHT, in CH2Cl2, while the metalation of the b and bacterial series macrocycles was carried out with a mixture of IMgBHT and lithium 2,2,6,6-tetramethylpiperidie in thiophene, all at ambient temperature.Both mono- and dimethalated derivatives were isolated and characterized in each case.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 15664-29-6